주식/증권
➡️ 중립
관련 뉴스
Fastly anticipates 2026 revenue of $744M-$748M amid $50M-$60M free cash flow outlook
2026/11/05
Cytokinetics outlines >50% new-to-brand share goal by year-end as MYQORZO expands into the U.K. this quarter
2026/11/05
TpvG expects $25m-$50m quarterly fundings going forward while extending incentive fee waiver through 2027
2026/11/05
BillionToOne raises 2026 revenue outlook to $460M-$470M while launching Northstar Clear on December 15
2026/11/05